Market revenue in 2021 | USD 5.9 million |
Market revenue in 2030 | USD 14.4 million |
Growth rate | 10.4% (CAGR from 2021 to 2030) |
Largest segment | Plants |
Fastest growing segment | Plants |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Animal, Plants, Synthetic |
Key market players worldwide | Amyris, Sophim, Kuraray Co Ltd, Croda International PLC, Arbe Robotics Ltd |
Plants was the largest segment with a revenue share of 83.05% in 2021. Horizon Databook has segmented the France squalene market based on animal, plants, synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
According to the European Federation of Pharmaceutical Industries and Association (EFPIA), the pharmaceuticals industry had one of the largest research and development budgets in France in 2021. It accounted for shares of 9.8% and 9.5%, respectively of overall pharmaceutical revenues and total business research in 2021.
Pharmaceutical manufacturers in France are continuously investing in research and development activities for producing innovative and effective medicines developed from bio-based ingredients to ensure environmental safety.
This, in turn, is expected to lead to the increased consumption of plantbased squalene in the pharmaceuticals industry in the country over the forecast period. Additionally, France is the third-largest importer of olive oil in Europe.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account